This Big-Cap "Ebola Stock" Is Also a Dividend Aristocrat

Over the past few weeks, one "clinical stage" pharma firm after another has seen its stock price rise and plummet on rumors about who has the...

The Best "Buy" of the New Dividend Aristocrats

If you are looking for a steady stream of safe dividends in today's troubled markets, the list of "Dividend Aristocrats" is a good place to start....

Pages 1 of 1